Top compounds associated with response to ACP5


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.00082 1
mRNA Bortezomib gCSI pan-cancer AAC -0.0015 1
mRNA Sorafenib GDSC1000 pan-cancer AAC -0.0012 1
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.0011 1
mRNA triptolide CTRPv2 pan-cancer AAC 0.00038 1
mRNA Bryostatin 1 FIMM pan-cancer AAC 0.00038 1
Download CSV